A Stock Recent News

San Francisco, California--(Newsfile Corp. - June 4, 2024) -  ePrep is delighted to announce a new partnership with Agilent - a global leader in technology platforms for analytical laboratories - for the distribution of the ePrep® ONE workstation in selected regions. The ePrep ONE is a fully automated solution for end-to-end chromatography sample preparation, which Agilent will be supplying alongside its extensive portfolio of laboratory instruments.

Examine the evolution of Agilent's (A) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc., (NYSE: A) is introducing two new products at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics. The Agilent 7010D Triple Quadrupole GC/MS System which targets the food and environmental markets, offers precision and sensitivity in gas chromatography-mass spectrometry. Additionally, the Agilent ExD Cell for use with the 6545XT AdvanceBio LC/Q-TOF system, serves the biopharma market and life science research. These ins.

BOSTON--(BUSINESS WIRE)--The following closed-end funds reported sources of distribution for May and this fiscal year to date. Distribution Period: May 2024   Ticker Tax-Exempt Funds Distribution Amount Per Share MAV Pioneer Municipal High Income Advantage Fund, Inc. $0.0325 MHI Pioneer Municipal High Income Fund, Inc. $0.0350 MIO Pioneer Municipal High Income Opportunities Fund, Inc. $0.0500 The following tables set forth estimates of the character of the current distribution and the cumulativ.

Agilent's (A) fiscal second-quarter results reflect weak momentum across all end markets.

Agilent Technologies, Inc. (NYSE:A ) Q2 2024 Results Conference Call May 29, 2024 4:30 PM ET Company Participants Parmeet Ahuja - Investor Relations Padraig McDonnell - President & Chief Executive Officer Bob McMahon - Senior Vice President & Chief Financial Officer Phil Binns - President of Agilent Life Sciences & Applied Markets Group Simon May - President of the Agilent Diagnostics and Genomics Group Angelica Riemann - President of Agilent CrossLab Group Conference Call Participants Matt Sykes - Goldman Sachs Jack Meehan - Nephron Research Patrick Donnelly - Citi Vijay Kumar - Evercore ISI Dan Brennan - TD Cowen Rachel Vatnsdal - JPMorgan Doug Schenkel - Wolfe Research Michael Ryskin - Bank of America Dan Arias - Stifel Josh Waldman - Cleeland Research Catherine Schulte - Baird Paul Knight - KeyBanc Operator Ladies and gentlemen, welcome to the Agilent Technologies Q2 2024 Earnings Call. My name is Regina, and I will be coordinating your call today.

While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended April 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Agilent Technologies (A) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.27 per share a year ago.

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.57 billion for the second quarter ended April 30, 2024, a decline of 8.4% reported and 7.4% core(1) compared to the second quarter of 2023. Second-quarter GAAP net income was $308 million, or $1.05 per share. This compares with $302 million, or $1.02 per share, in the second quarter of fiscal year 2023. Non-GAAP(2) net income was $356 million, or $1.22 per share during the quarter, compared wi.

Agilent Technologies' (A) second-quarter fiscal 2024 results are likely to reflect solid momentum across the ACG & DGG segments amid softness in the LSAG segment.